Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study.

Adv Radiat Oncol · 2022 · PMC8767250 · PMID 35071835

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

36 In a retrospective comparative study, Chang et al 27 reported fewer side effects in patients with breast cancer treated with TARE compared with TACE and also demonstrated a numerical trend for longer survival after TARE compared with TACE (12.9 vs 4.6 months), but the difference in survival was not statistically significant.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.